Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markolf Hanefeld

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Frontiers in Neurology|October 16, 2018
Sudomotor Testing of Diabetes PolyneuropathySarah-Maria Krieger, Manja Reimann, Rocco Haase, et al.
Folia Medica|November 7, 2013
Physical activity is strongly inversely related to post-challenge plasma glucose and glycemic spikes in a risk population for type 2 diabetesTheodora Temelkova-Kurktschiev, Tsvetan Stefanov, Carsta Koehler, et al.
Lancet (London, England)|June 28, 2002
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialJean-Louis Chiasson, Robert G Josse, Ramon Gomis, et al.
Stroke|April 10, 2004
Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose toleranceMarkolf Hanefeld, Jean Louis Chiasson, Carsta Koehler, et al.
JAMA|July 24, 2003
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trialJean-Louis Chiasson, Robert G Josse, Ramon Gomis, et al.
Current Medical Research and Opinion|June 15, 2007
Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetesMarkolf Hanefeld, Gary A Herman, Mei Wu, et al.
Diabetes & Vascular Disease Research|January 8, 2013
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studiesThomas Forst, Markolf Hanefeld, Stephan Jacob, et al.
Diabetes Care|September 18, 2013
Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmiasAnnett Stahn, Frank Pistrosch, Xenia Ganz, et al.
Acta Diabetologica|March 10, 2015
Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditionsFrank Pistrosch, Xenia Ganz, Stefan R Bornstein, et al.
Reviews in Endocrine & Metabolic Disorders|April 13, 2016
Determinants of mortality in patients with type 2 diabetes: a reviewJana Engelmann, Ulf Manuwald, Constanze Rubach, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Frontiers in Neurology|October 16, 2018
Sudomotor Testing of Diabetes PolyneuropathySarah-Maria Krieger, Manja Reimann, Rocco Haase, et al.
Folia Medica|November 7, 2013
Physical activity is strongly inversely related to post-challenge plasma glucose and glycemic spikes in a risk population for type 2 diabetesTheodora Temelkova-Kurktschiev, Tsvetan Stefanov, Carsta Koehler, et al.
Lancet (London, England)|June 28, 2002
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialJean-Louis Chiasson, Robert G Josse, Ramon Gomis, et al.
Stroke|April 10, 2004
Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose toleranceMarkolf Hanefeld, Jean Louis Chiasson, Carsta Koehler, et al.
JAMA|July 24, 2003
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trialJean-Louis Chiasson, Robert G Josse, Ramon Gomis, et al.
Current Medical Research and Opinion|June 15, 2007
Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetesMarkolf Hanefeld, Gary A Herman, Mei Wu, et al.
Diabetes & Vascular Disease Research|January 8, 2013
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studiesThomas Forst, Markolf Hanefeld, Stephan Jacob, et al.
Diabetes Care|September 18, 2013
Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular diseases: silent hypoglycemias and silent arrhythmiasAnnett Stahn, Frank Pistrosch, Xenia Ganz, et al.
Acta Diabetologica|March 10, 2015
Risk of and risk factors for hypoglycemia and associated arrhythmias in patients with type 2 diabetes and cardiovascular disease: a cohort study under real-world conditionsFrank Pistrosch, Xenia Ganz, Stefan R Bornstein, et al.
Reviews in Endocrine & Metabolic Disorders|April 13, 2016
Determinants of mortality in patients with type 2 diabetes: a reviewJana Engelmann, Ulf Manuwald, Constanze Rubach, et al.
Pageof 13